3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Observational
3
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
26
Lymphoid
3
Head & Neck
2
Genitourinary
2
Classical hematology
2
Thoracic
1
Other hematologic neoplasm
1
Other
1
Gynecologic
1
Conditions
Anemia, Refractory, with Excess of Blasts
255
Myelodysplastic Syndromes
228
Leukemia, Myeloid, Acute
228
Anemia
212
Leukemia
205
Precursor Cell Lymphoblastic Leukemia-Lymphoma
168
Leukemia, Myelomonocytic, Chronic
145
Neoplasms
142
Leukemia, Lymphocytic, Chronic, B-Cell
116
Myeloproliferative Disorders
114
Multiple Myeloma
113
Lymphoma, Non-Hodgkin
105
Thrombocytopenia
100
Lymphoma
98
Hodgkin Disease
91
Anemia, Refractory
81
Venous Thromboembolism
77
Congenital Abnormalities
77
Anemia, Aplastic
77
Primary Myelofibrosis
76
Lymphoma, Follicular
73
Leukemia, Myeloid, Chronic-Phase
70
Blast Crisis
67
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
65
Leukemia, Myeloid, Accelerated Phase
64
Lymphoma, Mantle-Cell
63
Febrile Neutropenia
62
Myelodysplastic-Myeloproliferative Diseases
58
Hematologic Neoplasms
56
Burkitt Lymphoma
56
Interventions
Medical Marijuana
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Crohn Disease
×
Classical hematology
×
Clear all
NCT03944447
2022-06-02
OMNI-Can
OMNI Medical Services, LLC
Phase 2
Unknown
200,000 enrolled
NCT02965209
2018-02-14
ENMSET
Evangelisches Krankenhaus Düsseldorf
Phase NA
Completed
136 enrolled